Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transplantation of Macroencapsulated Insulin-Producing Cells.

Current diabetes reports - 16 Jun 2018

Hwa Albert J, Weir Gordon C

Abstract excerpt

PURPOSE OF REVIEW: There is considerable interest in using macroencapsulation devices as a delivery strategy for transplanting insulin-producing cells. This review aims to summarize recent advances, to highlight remaining challenges, and to provide recommendations for the field. RECENT FINDINGS: A variety of new device designs have been reported to improve biocompatibility and to provide protection for islet/beta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kinetics
Share to Phenotype
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin-Secreting Cells

Share to Islets of Langerhans Transplantation

Source

Identifiers

PMID: 29909496
DOI: 10.1007/s11892-018-1028-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transplantation of Macroencapsulated Insulin-Producing Cells.PMID 29909496Read ↗

Beta‐cell replacement strategies for diabetesSemantic proximity Read ↗

Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In VivoSemantic proximity Read ↗

Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb.Semantic proximity Read ↗

Recent Advances in the Development of Bioartificial Pancreas Using 3D Bioprinting for the Treatment of Type 1 Diabetes: A ReviewSemantic proximity Read ↗

Bioprinting of Human Primary and iPSC-derived Islets with Retained and Comparable FunctionalitySemantic proximity Read ↗

Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue.Semantic proximity Read ↗

Towards 3D-Bioprinting of an Endocrine Pancreas: A Building-Block Concept for Bioartificial Insulin-Secreting TissueSemantic proximity Read ↗

A Continuously Oxygenated Macroencapsulation System Enables High-Density Packing and Delivery of Insulin-Secreting CellsSemantic proximity Read ↗

Clinical-grade cryopreservation unlocks transplant-ready human pancreatic and stem cell–derived islets for diabetes therapySemantic proximity Read ↗

Encapsulated, genetically engineered cells, secreting glucagon-like peptide-1 for the treatment of non-insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells.Semantic proximity Read ↗

Encapsulation of Human Islets in Novel Inhomogeneous Alginate-Ca<sup>2+</sup>/Ba<sup>2+</sup>Microbeads:<i>In Vitro</i>and<i>In Vivo</i>FunctionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.